AUG 26, 2016 11:19 AM PDT

Scientists Discover New Inflammatory Disease: Otulipenia

WRITTEN BY: Kara Marker
When four children from Pakistani and Turkish families presented with skin rashes and inflamed joints that doctors couldn’t explain, a team of researchers from the National Institutes of Health soon realized that the children all had an inflammatory disease that had never been seen before.
Credit: Darryl Leja, NHGRI
Following their research, NIH scientists are now referring to the disease as “otulipenia.” Based on what they’ve been able to learn about the disease since its discovery, the researchers believe it’s relatively rare and sometimes lethal, but treatable with anti-inflammatory drugs. Symptoms include fever, skin rashes, diarrhea, joint pain, and a “failure to grow or thrive.”

Using next-generation genetic sequencing of the four children with the disease, researchers quickly identified a malfunctioning protein encoded by a gene on chromosome 5 as the causative agent: a protein called OTULIN. 

"The malfunction in this protein has not been previously linked to clinical disorders of the human immune system," said Ivona Aksentijevich, MD, study co-author. "This discovery suggests a direction that can be explored for development of new therapies for patients with a wide range of inflammatory diseases."

In healthy individuals, OTULIN acts as a “deubiquitinase” enzyme, meaning it breaks a protein called ubiquitin. OTULIN is also known to play a role in regulating angiogenesis (the development of new blood vessels) and stimulation of the innate immune response by mobilizing immune cells and proteins.

However, it appears that OTULIN “misbehaves” a bit in cases of otulipenia. Specifically, processing of ubiquitin is disturbed: mutated OTULIN fails to remove ubiquitin proteins from certain molecules. This reaction leads to an abnormally high amount of inflammatory cytokines to be produced; when ubiquitin is properly taken care of by OTULIN, the protein then regulates the release of immune molecules, such as inflammatory cytokines.

The immune pathway that is disturbed from defective OTULIN leads to the various symptoms present in the children found with the disease, the researchers discovered.

A potential solution for the disease includes tumor necrosis factor (TNF) inhibitors, drugs that also successfully reduce inflammation in rheumatoid arthritis, another chronic inflammatory disease.

This study was recently published in the journal Proceedings of the National Academy of Sciences.
 


Source: UniProt, National Institutes of Health/National Human Genome Research institute
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
AUG 17, 2021
Immunology
Does Fasting Help Protect Against Infection?
AUG 17, 2021
Does Fasting Help Protect Against Infection?
Most people feeling under the weather, especially those with a fever, tend to lose their appetites. When recovering from ...
AUG 19, 2021
Immunology
Insights Into the Interplay Between COVID and the Nasal Microbiome
AUG 19, 2021
Insights Into the Interplay Between COVID and the Nasal Microbiome
There is a spectrum of COVID symptom severity: some recover after experiencing nothing more than a mild cough, while oth ...
AUG 24, 2021
Immunology
Women Produce More COVID Antibodies Than Men
AUG 24, 2021
Women Produce More COVID Antibodies Than Men
An exploration into the human immune response after a COVID-19 infection has revealed a surprising finding: women produc ...
AUG 30, 2021
Cancer
A Hot Approach to CAR T Cells
AUG 30, 2021
A Hot Approach to CAR T Cells
Immunotherapy, a type of treatment that targets a patient’s immune system to enhance the natural ability to attack ...
SEP 26, 2021
Coronavirus
LIBRA-Seq ID's a Potent Antibody to Fight COVID-19
SEP 26, 2021
LIBRA-Seq ID's a Potent Antibody to Fight COVID-19
Humans can produce millions or even billions of antibodies, so only so many can be captured and screened. But those anti ...
NOV 05, 2021
Cancer
The Labroots 2021 Cancer Research and Oncology Virtual Event Poster Winner
NOV 05, 2021
The Labroots 2021 Cancer Research and Oncology Virtual Event Poster Winner
Every year, Labroots hosts an exciting series of Virtual Events that focus on various scientific topics. These virtual m ...
Loading Comments...